ABBOTT LABORATORIES Income Taxes Paid
ABBOTT LABORATORIES (ABT) reported Income Taxes Paid of $620.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2017-02-17
- ABBOTT LABORATORIES income taxes paid for fiscal 2016 was $620.00M, a 1.74% decline from fiscal 2015.
- ABBOTT LABORATORIES income taxes paid for fiscal 2015 was $631.00M, a 40.85% increase from fiscal 2014.
- ABBOTT LABORATORIES income taxes paid for fiscal 2014 was $448.00M, a 56.88% decline from fiscal 2013.
- ABBOTT LABORATORIES income taxes paid for fiscal 2013 was $1.04B, a 23.99% decline from fiscal 2012.
| Period end | Income Taxes Paid 12 month | Income Taxes Paid 12 month as first filed |
|---|---|---|
| 2016-12-31 | $620.00M 10-K · filed 2017-02-17 | |
| 2015-12-31 | $631.00M 10-K · filed 2017-02-17 | |
| 2014-12-31 | $448.00M 10-K · filed 2017-02-17 | |
| 2013-12-31 | $1.04B 10-K · filed 2016-02-19 | |
| 2012-12-31 | $1.37B 10-K · filed 2015-02-27 | $1.37B 10-K · filed 2013-02-15 |
| 2011-12-31 | $1.78B 10-K · filed 2014-02-21 | $1.78B 10-K · filed 2012-02-21 |
| 2010-12-31 | $809.71M 10-K · filed 2013-02-15 | $945.00M 10-K · filed 2011-02-18 |
| 2009-12-31 | $635.45M 10-K · filed 2012-02-21 | $635.00M 10-K · filed 2011-02-18 |
| 2008-12-31 | $772.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |